Protagonist Therapeutics (PTGX) Q3 2026 Earnings

5AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-0.63
0.35
1.32
2.29

Details

Expected EPS
2.266298
Actual EPS
2.29
Surprise EPS
0.02
Surprise Percent
+1.05%

Description

Protagonist Therapeutics (PTGX) has reported earnings of 2.29 per share for Q3 2026.

0 Comments

Share your thoughts